Arbutus Biopharma
ABUS
#6260
Rank
โ‚ฌ0.56 B
Marketcap
2,95ย โ‚ฌ
Share price
-7.98%
Change (1 day)
6.43%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -โ‚ฌ64.72 Million

According to Arbutus Biopharma 's latest financial reports the company's current earnings are โ‚ฌ6.17 Million. , an increase over its 2023 earnings that were of -โ‚ฌ66.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ63.79 Million-4.02%
2023 -โ‚ฌ66.46 Million12.05%
2022 -โ‚ฌ59.31 Million-14.74%
2021 -โ‚ฌ69.56 Million19.61%
2020 -โ‚ฌ58.15 Million-61.69%
2019 -โ‚ฌ0.16 Billion171.23%
2018 -โ‚ฌ55.96 Million-43.58%
2017 -โ‚ฌ99.19 Million-77.77%
2016 -โ‚ฌ0.45 Billion532.77%
2015 -โ‚ฌ70.52 Million99.05%
2014 -โ‚ฌ35.43 Million175.82%
2013 -โ‚ฌ12.85 Million-143.7%
2012 โ‚ฌ29.39 M-399.11%
2011 -โ‚ฌ9.83 Million-39.03%
2010 -โ‚ฌ16.12 Million100.55%
2009 -โ‚ฌ8.04 Million-28.56%
2008 -โ‚ฌ11.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ32.18 M-150.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ1.98 Million-96.91% Bahamas